06/12/2022 : Amandine Ferrière
Supervisor: Patrick Blanco /Vanja Sisirak
07/12/2022: Eoghann White
Supervisor: Victor Appay
12/12/2022: Céline Blaye
Supervisor: Nicolas Larmonier
14/12/2022: Gaël Galli
Supervisor: Maya Saleh
Best poster Award at the 18th GSO days (30/11-2/12) in Montpellier to Thomas BOYER, PhD student.
Domitile Chalopin was awarded for Best Talk of the Département de Sciences Biologiques et Médicales (05/12/2022).
Congratulations!
Best poster Award at the 9th Immunotherapy of Cancer Conference (sept 2022)
Domitile Chalopin (on the right of the photo) received the Best Poster award of the 9th Immunotherapy of Cancer Conference, held in Munich.
The Domitile’s poster is about “Innate immunity atlas of hepatocellular carcinoma unravels the differentiation hierarchy of myeloid NK cells and MDSCs”
During the congress, Maya Saleh presented her work untitled “Single cell and spatial transcriptomics unravel a NASH-associated innate immunity contexture in hepatocellular carcinoma associated with poor response to immunotherapy”.
Congratulations!
The Master 2 “Innovations en Santé” will open in 2022-2023.
It will focus on Immunology, with 3 possible axes: Immuno-infectiology; Immuno-inflammation ; Immuno-oncology
It has been specially designed for medicine, pharmacy and odontology applicants to a 2nd year-Master
Further information here!
Heloïse Tudela, PhD in the Team 3 will talk about Microbiome.
11th may, 7pm @Levrette Café, Bordeaux.
Book here!
September 2022:
Maya Saleh organizes and participates to the “9th Immunotherapy of Cancer Conference” in Munich, Germany
24/03/2022 : Corentin Le-Saos—Patrinos
« L’implication des lymphocytes T folliculaires helper dans la leucémie lymphoïde chronique »
Supervisor : Dorothée Duluc
Jury : Yves renaudineau, Pierre Milpied, Pierre Soubeyran,Patricia Amé.
28/03/2022 : Adrien Duran
« Pathogénicité des lymphocytes dérivés de l’intestin dans la sclérose en plaques»
Supervisor : Nathalie Schmitt
Ribal MEHRI, doctorant d’ImmunoConcEpT en Demi-finale 2022 du concours Ma Thèse en 180s
3 mars 2022 – 13 h45 Agora – domaine du Haut-Carré – Université de Bordeaux, 43 rue Pierre Noailles à Talence
MEHRI Ribal
Doctorant en immunologie
École doctorale : Sciences de la vie et de la santé
Laboratoire : Immunologie conceptuelle, expérimentale et translationnelle (Immunoconcept)
Thèse : Impact de médiateurs inflammatoires sur la perte de mélanocytes au cours du vitiligo
https://www.u-bordeaux.fr/Evenements/De-la-vie-de-campus/Demi-finale-2022-du-concours-Ma-These-en-180s
by Jonathan Sholl, Gregory D.Sepich-Poore, Rob Knight & Thomas Pradeu
Published: November 26, 2021 in Trends in Cancer
https://doi.org/10.1016/j.trecan.2021.10.008
The unexpected roles of the microbiota in cancer challenge explanations of carcinogenesis that focus on tumor-intrinsic properties. Most tumors contain bacteria and viruses, and the host’s proximal and distal microbiota influence both cancer incidence and therapeutic responsiveness. Continuing the history of cancer–microbe research, these findings raise a key question: to what extent is the microbiota relevant for clinical oncology? We approach this by critically evaluating three issues: how the microbiota provides a predictive biomarker of cancer growth and therapeutic responsiveness, the microbiota’s causal role(s) in cancer development, and how therapeutic manipulations of the microbiota improve patient outcomes in cancer. Clarifying the conceptual and empirical aspects of the cancer-associated microbiota can orient future research and guide its implementation in clinical oncology.
All right reserved © immunoconcept.cnrs.fr 2022 by Nivo-Web